The U.S. side has repeatedly generalized the concept of national security and abused its national power to maliciously suppress Chinese companies, which China firmly opposes.
Shuang Juting said the U.S. approach not only harms the legitimate rights and interests of Chinese companies, but also affects the interests of U.S. companies and consumers, and undermines the order of international trade and commerce and trade rules, which is detrimental to the U.S. and China and the whole world. The U.S. side should immediately correct its wrong practices, stop politicizing and weaponizing economic and trade issues, and treat enterprises of all countries, including Chinese enterprises, fairly.
China will take necessary measures to firmly safeguard the legitimate rights and interests of Chinese enterprises.
Media reports
Extra
Ministry of Commerce: Challenging the Inflation Reduction Act is a manifestation of China's exercise of its rights in accordance with WTO rules
The WTO Council for Trade in Goods recently held an official meeting in Geneva, Switzerland. The Chinese delegation expressed serious concern over the recent introduction of a number of trade-discriminatory and distorting subsidy measures in the Inflation Reduction Act as well as a series of U.S. policy measures to disrupt the global semiconductor industry chain and supply chain.
Ministry of Commerce spokeswoman Shuang Juting said at a regular press conference on the afternoon of Dec. 1 that, as a member of the WTO, it is a concrete manifestation of China's right to exercise its rights in accordance with the WTO rules to raise concerns and questions in the relevant WTO committees about trade measures taken by other members and their impacts.
Shuang Juting said that at the meeting of the WTO Council for Trade in Goods held on Nov. 24-25, the Chinese side analyzed the relevant provisions of the U.S. bill suspected to be in violation of WTO rules item by item in its statement from a professional point of view, pointing out that the U.S. practice seriously disrupts international trade and investment, undermines the stability of the global industrial chain supply chain and expresses serious concern over the U.S. double standard on the rules of international trade and the bullying behavior of the U.S. on international trade rules.
China urged the U.S. side to strictly fulfill its obligations under WTO rules and effectively safeguard the authority and effectiveness of the multilateral trading system.
In a 40-minute-long statement at the WTO meeting, the Chinese delegation pointed out that the U.S. side's Inflation Reduction Act would provide up to $369 billion in subsidies to support the production of and investment in electric vehicles, key minerals, clean energy and power-generating facilities, with as many as nine of the tax incentives contingent on production and sales on U.S. soil or in North America. The above discriminatory provisions are suspected of violating the WTO's basic principles of most-favored-nation treatment and national treatment, and are suspected of constituting import-substitution subsidies and trade-related investment restrictions prohibited by the WTO, and have begun to cause serious distortions in global trade and investment in the relevant industries, triggering a high degree of concern among governments and industries.
In addition, in response to the recent introduction of the United States of America's new semiconductor export control regulations on China and the Chip and Science Act, China pointed out in its statement that the United States not only generalizes "national security" and abuses export control, which is suspected of violating the WTO rules, but also implements the "long arm jurisdiction" to force other members to take measures in violation of the WTO rules, which is a violation of the WTO rules.
The United States not only generalizes "national security" and abuses export control, suspected of violating WTO rules, but also forces other members to comply with U.S. policies by implementing "long-arm jurisdiction" and violating WTO rules, which is pushing unilateralism to the extreme, seriously violating the basic principle of national sovereignty in international law, and is typical of the practice of hegemony and Cold War mentality.
Shuang Juting further emphasized at a press conference on the afternoon of Dec. 1, "At present, economic globalization has encountered a countercurrent and the world economic recovery is weak. In the face of global challenges, China is willing to work with other members to implement the results reached at the 12th WTO Ministerial Conference, participate fully and y in the WTO reform negotiations, oppose unilateralism and protectionism, and promote the WTO to play a better role in contributing to the maintenance of the stability of the global industrial chain supply chain and promoting the recovery of the world economy as soon as possible."
Extended reading:
The United States once again suppressed ZTE Huawei but in the field of medical appliances to China hurt
The United States of America on the Chinese science and technology enterprises to suppress, can be described as nothing to do. Recently, the United States has introduced new norms, of course, deducted or "threat to U.S. national security" crooked hat. However, China is not without constraints on the U.S. In the medical equipment, China let the U.S. and the European Union can do nothing.
November 25, the U.S. Federal Communications Commission said it had voted unanimously to adopt new norms that would prohibit the import or sale of certain technology products that pose a security risk to U.S. critical infrastructure. It was the latest in years of escalating U.S. restrictions on Chinese technology, which began under Trump and were renewed by the Biden administration.
Rosenworcel, a Democrat who chairs the commission, said in a statement, "The FCC is committed to protecting U.S. national security by ensuring that untrustworthy communications equipment is not authorized for use within our borders, and we will continue to do this work."
Under the new specifications, the U.S. will ban the sale of communications equipment made by Huawei and ZTE and restrict the use of some Chinese-made video surveillance systems, including products from Hikvision, Dahua and Hinergy, on the grounds that they pose an unacceptable risk to U.S. national security.
The FCC's order applies to future equipment authorizations, though the agency left open the possibility that it could revoke previous authorizations.
Communications commissioner Carr, a member of the **** and GOP, tweeted, "As a result of our order, no new Huawei or ZTE equipment can be authorized. Nor can any new Dahua, Hikvision, or Hynectar equipment be approved unless they assure the FCC that their equipment will not be used for public **** security, government facility security, and other national security purposes."
The U.S. is suppressing China in the technology sector, but it's hurting for medical devices.
China is one of Europe's major trading partners in medical devices and equipment, accounting for 12 percent of exports to the European medical equipment market in 2021 alone. But the European Union and the United States argue that China is pursuing protectionist policies in the medical device sector, claiming that China takes various measures to support its domestic medical device industry.
As China is not a party to the World Trade Organization's Agreement on Government Procurement (GPA), it has only been able to negotiate verbally with China.
Pharmaceuticals and medical devices will reportedly be on the agenda of the 3rd meeting of the Committee on Trade and Technology between the U.S. government and the European Union's executive committee, which will be held in Washington on Dec. 5 next year.
The Trade and Technology Committee, established in June 2021, is an initiative organization that provides a permanent platform for transatlantic cooperation on key global trade, economic and technology issues. In the draft, the U.S. and the European Union expressed "concern about the threat posed by a range of non-market policies and practices," such as in the area of medical devices. Medical device importers report that China's tenders, which were previously open to imports, now specifically require the use of domestic products.
In response, the EU's executive committee said it had been expressing concerns about market release barriers to the Chinese authorities.
The draft from the Committee on Trade and Technology says the U.S. and EU have analyzed and exchanged relevant data and examined the market share of U.S. and EU medical device companies in China to understand the challenges of the impact on U.S. and EU companies.
In fact, it's useless for the US and EU to express any more concern, as the Chinese government has its own reasons for supporting its domestic medical device industry, which is mostly for the sake of the public. Take the cardiac stent for example, the original a cardiac stent 20,000 yuan, now the state through centralized purchasing, increase production and other measures, a cardiac stent of the same quality down to a few hundred dollars a, the quality of domestic stents is not inferior to the imported stents, so why do people have to use the price of super-expensive imported cardiac stents it?